Bespoke Extracts (BSPK) 10-Q 18 Jul 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	May 31, 2017	Jul. 15, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Bespoke Extracts, Inc.
Entity Central Index Key	1,409,197
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Document Type	10-Q
Trading Symbol	BSPK
Document Period End Date	May 31, 2017
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,017
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		25,822,712

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	May 31, 2017	Aug. 31, 2016
Current assets
Cash	$ 158,046	$ 431
Total current assets	158,046	431
Domain names, net of amortization of $836	49,349
Intellectual property, net of amortization of $0 and $657, respectively		1,314
Total assets	207,395	1,745
Current liabilities
Accounts payable and accrued liabilities	19,798	69,426
Accounts payable - related party		14,609
Note payable - related party	153,050	31,500
Convertible note payable, net of unamortized discount $371,139	168,861
Total current liabilities	341,709	115,535
Stockholders' Deficit
Series A Convertible Preferred Stock, $0.001 par value, 50,000,000 authorized shares; no shares issued and outstanding as of May 31, 2017 and August 31, 2016, respectively
Common stock, $0.001 par value: 800,000,000 authorized; 45,622,712 and 2,922,712 shares issued and outstanding as of May 31, 2017 and August 31, 2016, respectively	45,623	2,923
Common stock payable - 200,000 shares	30,000
Additional paid-in capital	7,563,087	2,310,876
Accumulated deficit	(7,773,024)	(2,427,589)
Total stockholders' deficit	(134,314)	(113,790)
Total liability and stockholders' deficit	$ 207,395	$ 1,745

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($)	May 31, 2017	Aug. 31, 2016
Statement of Financial Position [Abstract]
Net of amortization cost	$ 836
Amortization of intangible assets	0	657
Unamortized discount net	$ 371,139
Series A convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series A convertible preferred stock, shares authorized	50,000,000	50,000,000
Series A convertible preferred stock, shares issued
Series A convertible preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	800,000,000	800,000,000
Common stock, shares issued	45,622,712	2,922,712
Common stock, shares outstanding	45,622,712	2,922,712
Number of common stock payable	200,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2017	May 31, 2016	May 31, 2017	May 31, 2016
Operating expenses:
Selling, general and administrative expenses	$ 16,543	$ 4,869	$ 30,807	$ 15,662
Payroll expense	21,829	21,124	67,515	62,636
Professional fees	28,000	38,500	41,613	108,192
Consulting	73,750	4,675	73,750	122,584
Brand development			10,000
Formula development			7,500
Compensation	5,088,421		5,088,421
Impairment of intellectual property			1,248
Amortization expense	836	33	902	99
Total operating expenses	5,229,379	69,201	5,321,756	309,173
Loss from operations	(5,229,379)	(69,201)	(5,321,756)	(309,173)
Other expense
Interest expense	(9,383)	(60)	(12,327)	(60)
Amortization of debt discounts	(11,352)		(11,352)
Total other expense	(20,735)	(60)	(23,679)	(60)
Loss before income tax	(5,250,114)	(69,261)	(5,345,435)	(309,233)
Provision for income tax
Net Loss	$ (5,250,114)	$ (69,261)	$ (5,345,435)	$ (309,233)
Net loss per share: basic and diluted	$ (0.28)	$ (0.02)	$ (0.65)	$ (0.11)
Weighted average shares outstanding basic and diluted	18,520,538	2,923,907	8,179,122	2,815,848

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	May 31, 2017	May 31, 2016
Cash flows from operating activities
Net loss	$ (5,345,435)	$ (309,233)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization expense	902	99
Amortization of debt discount	11,351
Stock based compensation	5,088,421
Impairment of intellectual property	1,248
Changes in operating assets and liabilities
Accounts payable	(62,320)	19,641
Accounts payable - related party	(14,609)
Accrued interest expense	12,692	60
Prepaid expense		95,375
Net Cash used in operating activities	(307,750)	(194,058)
Cash flows from investing activities
Proceeds from note payable, related party		12,500
Cash paid for domain names	(20,185)
Net cash used in investing activities	(20,185)	12,500
Cash flow from financing activities
Payment of note payable - related party	(5,500)
Proceeds from exercise of warrants	4,000
Borrowings on convertible debt	360,000
Proceeds from note payable - related party	127,050
Net cash provided by financing activities	485,550
Net increase in cash and cash equivalents	157,615	(181,558)
Cash and cash equivalents at beginning of period	431	185,869
Cash and cash equivalents at end of period	158,046	4,311
Cash paid during period for
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:
Common stock payable issued for acquisition of domain names	30,000
Stock issued with debt	157,509
Warrants issued with debt	44,981
Common stock issued for stock payable		$ 210,000

Basis of Presentation

Basis of Presentation	9 Months Ended
	May 31, 2017
Basis of Presentation [Abstract]
BASIS OF PRESENTATION	NOTE 1 —BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements of Bespoke Extracts, Inc. (formerly known as DiMi Telematics International, Inc.), a Nevada corporation (the “Company”), have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. These unaudited consolidated financial statements and related notes should be read in conjunction with the Company's annual report on Form 10-K for the fiscal year ended August 31, 2016. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly the financial position of the Company as of May 31, 2017, and the results of operations and cash flows for the three and nine months ended May 31, 2017 and May 31, 2016. The results of operations for the three and nine months ended May 31, 2017 are not necessarily indicative of the results that may be expected for the entire fiscal year. Certain prior period amounts have been reclassified to conform to current period presentation. Going Concern The accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The Company has reported a net loss of $5,345,435 for the nine months ended May 31, 2017 and had a working capital deficit of $183,663 as of May 31, 2017. These conditions raise substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial statements do not contain any adjustments that may result from the outcome of this uncertainty. Research and Development Research and development costs and brand development costs are expensed as incurred. Development costs of product to be sold are subject to capitalization beginning when a product’s feasibility has been established and ending when a product is available for general release to customers. In most instances, the Company’s products are released soon after technological feasibility has been established. Costs incurred for development are capitalized. Amortization is recorded over the estimated useful lives of the assets, generally, 5 years. For the nine months ended May 31, 2017 the Company expensed $10,000 compared to $0 for the nine months ended May 31, 2016, for brand development. Formula development for the nine months ended May 31, 2017 amounted to $7,500 compared to $0 for the nine months ended May 31, 2016.

Equity

Equity	9 Months Ended
	May 31, 2017
Equity [Abstract]
EQUITY	2. EQUITY Common Stock The Company was formed in the state of Nevada on April 13, 2006. The Company has authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. On October 1, 2015, the Board of Directors and a majority of the Company’s shareholders approved an amendment of the Company’s Articles of Incorporation to effect a one (1) for three (3) reverse stock split of the Company’s outstanding common stock (the “Reverse Split”). The Reverse Split became effective on December 1, 2015. As a result of the Reverse Split, each three (3) shares of common stock issued and outstanding prior to the Reverse Split have been converted into one (1) share of common stock. The effect of the Reverse Split has been applied retroactively throughout this quarterly report. On February 21, 2017, the Company recognized a stock payable of $30,000 associated with 200,000 shares committed to be issued for the purchase of certain domain names (see Note 4). On March 10, 2017, the Company changed its name to Bespoke Extracts, Inc. (formerly known as DiMi Telematics International, Inc.). On April 11, 2017, the Company issued 2,700,000 shares of common stock in connection with the issuance of a convertible note with a principal amount of $540,000 (see Note 6). The relative fair value of the stock of $157,509 was recognized as a discount to the note that is being amortized to interest expense over the life of the note.

Warrants

Warrants	9 Months Ended
	May 31, 2017
Warrants [Abstract]
WARRANTS	3. WARRANTS During the nine months ended May 31, 2017, warrant activity included the following: Warrants granted on March 14, 2017, the Company entered into an employment agreement with Barry Tenzer to continue as CEO of the Company. In connection with the employment agreement the Company issued Mr. Tenzer a warrant to purchase up to 20,000,000 share of common stock at a per share price of $0.0001. The warrant was exercised in full on March 28, 2017. On May 22, 2017, Barry Tenzer resigned as President and Chief Executive Officer. In connection with the resignation of Mr. Tenzer, the 20,000,000 shares of stock issued upon the exercise of the warrants was returned to the company and cancelled and the exercise proceeds of $2,000 were returned to Mr. Tenzer subsequent to May 31, 2017. The fair value of the warrants was determined to be $4,998,021 which was recognized as compensation expense during the nine months ended May 31, 2017. The following table summarizes the warrant activity issued to Barry Tenzer during the nine months ended May 31, 2017: Number of Weighted-Average Outstanding at August, 2016 - $ - Granted 20,000,000 .0001 Canceled or expired - - Exercised 20,000,000 .0001 Outstanding at May 31, 2017 - $ - O The following table summarizes the warrant activity issued to Marc Yahr during the nine months ended May 31, 2017: Number of Weighted-Average Outstanding at August, 2016 - $ - Granted 20,000,000 .0001 Canceled or expired - - Exercised 20,000,000 .0001 Outstanding at May 31, 2017 - $ - On April 11, 2017, the Company executed a $540,000 Convertible Debenture with an original issue discount of $180,000. The note has a 9% interest rate and a term of two years. In connection with the note, the Company issued the lender 900,000 warrants with a term of 3 years and an exercise price of $1.00. The relative fair value of the warrants $44,981 was recognized as a discount to the note. Number of Weighted-Average Outstanding at August, 2016 - $ - Granted 900,000 1.00 Canceled or expired - - Exercised - - Outstanding at May 31, 2017 900,000 $ 1.00 The fair value of the warrants was estimated using the Black-Scholes option pricing model and the following range of assumptions: Grant Date Risk-free interest rate at grant date 1.06% – 1.44 % Expected stock price volatility 117% – 362 % Expected dividend payout - Expected option in life-years 1 – 3 years

Asset Purchase Agreement

Asset Purchase Agreement	9 Months Ended
	May 31, 2017
Asset Purchase Agreement [Abstract]
ASSET PURCHASE AGREEMENT	4. ASSET PURCHASE AGREEMENT On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain the domain names set forth in an asset purchase agreement for a total approximately $20,000 and 200,000 shares of the Company’s common stock valued at $30,000. As of May 31, 2017, the stock had not been issued and a total of $30,000 common stock payable is recorded.

Intellectual Property

Intellectual Property	9 Months Ended
	May 31, 2017
Intellectual Property [Abstract]
INTELLECTUAL PROPERTY	5. INTELLECTUAL PROPERTY The Company executed an Asset Purchase Agreement on August 28, 2011 which included the acquisition of various types of intellectual property. The Company elected to suspend further investment and working capital on developing the Company’s technology and business prospects. The Company has recognized a loss on impairment of intellectual property in the amount of $1,248 as of May 31, 2017.

Notes Payable

Notes Payable	9 Months Ended
	May 31, 2017
Notes Payable [Abstract]
NOTES PAYABLE	6. NOTES PAYABLE On April 27, 2016, the Company issued our CEO a 7% unsecured promissory note in the amount of $2,500 which matured six months from the date of issuance. On July 5, 2016, the Company issued our CEO a 7% unsecured note in the amount of $3,000 which matured six months from date of issuance. On November 17, 2016, the Company repaid the principal amount of the notes, or $5,500. The changes in these notes payable to related party consisted of the following during the nine months ended May 31, 2017 and the year ended August 31, 2016: May 31, August 31, 2016 Notes payable – related party at beginning of period $ 5,500 $ - Payments on notes payable – related party (5,500 ) - Borrowings on notes payable – related party 50 5,500 Convertible debenture – related party at end of period $ 50 $ 5,500 On May 17, 2016, the Company issued to Lyle Hauser, the Company’s largest shareholder, a 7% unsecured promissory note in the amount of $10,000 which matured six months from the date of issuance. On August 15, 2016, the Company issued a significant shareholder a 7% unsecured promissory note in the amount of $16,000 which matures six months from the date of issuance. On October 27, 2016, the Company issued a significant shareholder a 7% unsecured promissory note in the amount of $10,000 which matures six months from the date of issuance. The preceding notes have matured and remain unpaid at the quarter ended May 31, 2017. On November 14, 2016, the Company issued a significant shareholder 7% unsecured promissory note in the amount of $80,000 which matures six months from the date of issuance. On February 17, 2017, the Company issued a significant shareholder 7% unsecured promissory note in the amount of $30,000 which matures six months from the date of issuance. On March 31, 2017, the Company issued a significant shareholder 7% unsecured promissory note in the amount of $7,000 which matures six months from the date of issuance. The changes in notes payable to related party consisted of the following during the nine months ended May 31, 2017 and the year ended August 31, 2016: May 31, August 31, 2016 Notes payable – related party at beginning of period $ 26,000 $ - Payments on notes payable – related party - - Borrowings on notes payable – related party 127,000 26,000 Convertible debenture – related party at end of period $ 153,000 $ 26,000 On April 11, 2017, the Company executed a $540,000 Convertible Debenture with an original issue discount of $180,000. The note has a 9% interest rate and a term of two years. In connection with the note, the Company issued the lender an aggregate of 2,700,000 shares and 900,000 warrants. The relative fair value of the stock and warrants aggregating $202,490 was recognized as a discount to the note. Amortization of $11,351 was recognized during the nine months ended May 31, 2017. The conversion price of the outstanding balance is the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the note the lender is entitled to receive the greater of 5% every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principle. May 31, Convertible debenture $ 540,000 Unamortized discount (371,139 ) Convertible debenture, net of unamortized discount $ 168,861

Employment Agreement

Employment Agreement	9 Months Ended
	May 31, 2017
Employment Agreement [Abstract]
EMPLOYMENT AGREEMENT	7. EMPLOYMENT AGREEMENT On March 14, 2017, the Company entered into a two year employment agreement with Barry Tenzer to continue as CEO of the Company. In connection with the employment agreement the Company issued Mr. Tenzer a warrant to purchase up to 20,000,000 share of common stock at a per share price of $0.0001. The warrant was exercised in full on March 28, 2017. The shares of common stock underlying the warrant were issued on April 6, 2017. On May 22, 2017, Barry Tenzer resigned as President and Chief Executive Officer of Bespoke Extracts, Inc. Mr. Tenzer’s resignation was not the result from any disagreement with the Company, any matter related to the Company’s operations, policies or practices, the Company’s management or the Board. In connections with the resignation of Mr. Tenzer his stock issued from his employment agreement has been returned to the company subsequent to May 31, 2017. On May 22, 2017, the Board of Directors of the Company appointed Marc Yahr as President and Chief Executive Officer of the Company and as a member of the Company’s Board. There are no family relationships between Mr. Yahr and any of our other officers and directors. O

Related Party Transactions

Related Party Transactions	9 Months Ended
	May 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS We currently lease approximately 500 square feet of general office space at 290 Lenox Avenue, New York, NY 10027 from our Executive Vice President – Business Development. On April 27, 2016, the Company issued our CEO two 7% unsecured promissory note in the aggregate amount of $5,500 which notes matured six months from the date of issuance. Both notes have been paid off and the remaining principal amount is $0. On May 17, 2016, the Company issued to Lyle Hauser, the Company’s largest shareholder, a 7% unsecured promissory note in the amount of $10,000 which matured six months from the date of issuance. The note has matured and remains unpaid at the quarter ended May 31, 2017. On August 15, 2016, the Company issued a significant shareholder a 7% unsecured promissory note in the amount of $16,000 which matures six months from the date of issuance. The note has matured and remains unpaid at the quarter ended May 31, 2017. As of August 31, 2016, the Company had an outstanding payable of $14,609 to the CEO. The payable is unsecured, due on demand and bears no interest. As of May 31, 2017 the accounts payable – related party has been paid and currently has a balance of $0. On October 27, 2016 the Company issued a significant shareholder a 7% unsecured promissory notes totaling $10,000 which matures six months from the date of issuance. The note has matured and remains unpaid at the quarter ended May 31, 2017 One November 14, 2016 the Company issued a significant shareholder a 7% unsecured promissory note totaling $80,000 which matures six months from the date of issuance. On February 17, 2017, the Company issued a significant shareholder a 7% unsecured promissory note in the amount of $30,000 which matures six months from the date of issuance. On March 31, 2017, the Company issued a significant shareholder 7% unsecured promissory note in the amount of $7,000 which matures six months from the date of issuance.

Subsequent Events

Subsequent Events	9 Months Ended
	May 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	9. SUBSEQUENT EVENTS As of June 10, 2017, the Company issued an aggregate of 40,000,000 shares of common stock pursuant to the exercise of warrants for proceeds of $4,000. On June 29, 2017, the Company issued 200,000 shares of common stock committed to be issued for the purchase of certain domain names (see Note 4). On June 29, 2017, in connection with the resignation of Mr. Tenzer, the 20,000,000 shares of stock issued upon the exercise of the warrants was returned to the Company and cancelled and the exercise proceeds of $2,000 were returned to Mr. Tenzer.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	May 31, 2017
Basis of Presentation [Abstract]
Basis of Presentation	BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements of Bespoke Extracts, Inc. (formerly known as DiMi Telematics International, Inc.), a Nevada corporation (the “Company”), have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete consolidated financial statements. These unaudited consolidated financial statements and related notes should be read in conjunction with the Company's annual report on Form 10-K for the fiscal year ended August 31, 2016. In the opinion of management, these unaudited consolidated financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly the financial position of the Company as of May 31, 2017, and the results of operations and cash flows for the three and nine months ended May 31, 2017 and May 31, 2016. The results of operations for the three and nine months ended May 31, 2017 are not necessarily indicative of the results that may be expected for the entire fiscal year. Certain prior period amounts have been reclassified to conform to current period presentation.
Going Concern	Going Concern The accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The Company has reported a net loss of $5,345,435 for the nine months ended May 31, 2017 and had a working capital deficit of $183,663 as of May 31, 2017. These conditions raise substantial doubt about our ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. The accompanying financial statements do not contain any adjustments that may result from the outcome of this uncertainty.
Research and Development	Research and Development Research and development costs and brand development costs are expensed as incurred. Development costs of product to be sold are subject to capitalization beginning when a product’s feasibility has been established and ending when a product is available for general release to customers. In most instances, the Company’s products are released soon after technological feasibility has been established. Costs incurred for development are capitalized. Amortization is recorded over the estimated useful lives of the assets, generally, 5 years. For the nine months ended May 31, 2017 the Company expensed $10,000 compared to $0 for the nine months ended May 31, 2016, for brand development. Formula development for the nine months ended May 31, 2017 amounted to $7,500 compared to $0 for the nine months ended May 31, 2016.

Warrants (Tables)

Warrants (Tables)	9 Months Ended
	May 31, 2017
Related Party Transaction [Line Items]
Summarizes of relative fair value of the warrants	Number of Weighted-Average Outstanding at August, 2016 - $ - Granted 900,000 1.00 Canceled or expired - - Exercised - - Outstanding at May 31, 2017 900,000 $ 1.00
Schedule of share based payment award stock warrants valuation assumptions	Grant Date Risk-free interest rate at grant date 1.06% – 1.44 % Expected stock price volatility 117% – 362 % Expected dividend payout - Expected option in life-years 1 – 3 years
Barry Tenzer [Member]
Related Party Transaction [Line Items]
Summarizes the warrant activity issued	Number of Weighted-Average Outstanding at August, 2016 - $ - Granted 20,000,000 .0001 Canceled or expired - - Exercised 20,000,000 .0001 Outstanding at May 31, 2017 - $ -
Marc Yahr [Member]
Related Party Transaction [Line Items]
Summarizes the warrant activity issued	Number of Weighted-Average Outstanding at August, 2016 - $ - Granted 20,000,000 .0001 Canceled or expired - - Exercised 20,000,000 .0001 Outstanding at May 31, 2017 - $ -

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	May 31, 2017
Notes Payable [Abstract]
Schedule of notes payable to related party	May 31, August 31, 2016 Notes payable – related party at beginning of period $ 5,500 $ - Payments on notes payable – related party (5,500 ) - Borrowings on notes payable – related party 50 5,500 Convertible debenture – related party at end of period $ 50 $ 5,500 May 31, August 31, 2016 Notes payable – related party at beginning of period $ 26,000 $ - Payments on notes payable – related party - - Borrowings on notes payable – related party 127,000 26,000 Convertible debenture – related party at end of period $ 153,000 $ 26,000
Schedule of convertible debenture net of unamortized discount	May 31, Convertible debenture $ 540,000 Unamortized discount (371,139 ) Convertible debenture, net of unamortized discount $ 168,861

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2017	May 31, 2016	May 31, 2017	May 31, 2016
Basis of Presentation (Textual)
Net loss	$ (5,250,114)	$ (69,261)	$ (5,345,435)	$ (309,233)
Working capital deficit	183,663		$ 183,663
Amortization estimated useful lives of the assets			5 years
Brand development expenses			$ 10,000
Formula development			$ 7,500

Equity (Details)

Equity (Details) - USD ($)	Apr. 11, 2017	Feb. 21, 2017	Oct. 01, 2015	May 31, 2017	Aug. 31, 2016
Equity (Textual)
Common stock, shares authorized				800,000,000	800,000,000
Common stock, par value				$ 0.001	$ 0.001
Preferred stock, shares authorized				50,000,000	50,000,000
Preferred stock, par value				$ 0.001	$ 0.001
Reverse stock split			1 for 3
Stock issued during period, value		$ 30,000
Stock issued during period, shares	2,700,000	200,000
Principal amount	$ 540,000
Fair value of amortized discount	$ 157,509

Warrants (Details)

Warrants (Details) - Warrants [Member]	9 Months Ended
	May 31, 2017$ / sharesshares
Class of Warrant or Right [Line Items]
Number of Warrants outstanding, Beginning Balance | shares
Number of Warrants, Granted | shares	900,000
Number of Warrants, Canceled or expired | shares
Number of Warrants, Exercised | shares
Number of Warrants, Outstanding Ending Balance | shares	900,000
Weighted-Average Price Per Share, Outstanding Beginning Balance | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	1
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Exercised | $ / shares
Weighted-Average Price Per Share, Outstanding Ending Balance | $ / shares	$ 1
Barry Tenzer [Member]
Class of Warrant or Right [Line Items]
Number of Warrants outstanding, Beginning Balance | shares
Number of Warrants, Granted | shares	20,000,000
Number of Warrants, Canceled or expired | shares
Number of Warrants, Exercised | shares	20,000,000
Number of Warrants, Outstanding Ending Balance | shares
Weighted-Average Price Per Share, Outstanding Beginning Balance | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	0.0001
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Exercised | $ / shares	0.0001
Weighted-Average Price Per Share, Outstanding Ending Balance | $ / shares

Warrants (Details 1)

Warrants (Details 1) - Warrants [Member]	9 Months Ended
	May 31, 2017$ / sharesshares
Class of Warrant or Right [Line Items]
Number of Warrants outstanding, Beginning Balance | shares
Number of Warrants, Granted | shares	900,000
Number of Warrants, Canceled or expired | shares
Number of Warrants, Exercised | shares
Number of Warrants, Outstanding Ending Balance | shares	900,000
Weighted-Average Price Per Share, Outstanding Beginning Balance | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	1
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	1
Weighted-Average Price Per Share, Outstanding Ending Balance | $ / shares	$ 1
Marc Yahr [Member]
Class of Warrant or Right [Line Items]
Number of Warrants outstanding, Beginning Balance | shares
Number of Warrants, Granted | shares	20,000,000
Number of Warrants, Canceled or expired | shares
Number of Warrants, Exercised | shares	20,000,000
Number of Warrants, Outstanding Ending Balance | shares
Weighted-Average Price Per Share, Outstanding Beginning Balance | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	0.0001
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	0.0001
Weighted-Average Price Per Share, Outstanding Ending Balance | $ / shares

Warrants (Details 2)

Warrants (Details 2) - Warrants [Member]	9 Months Ended
	May 31, 2017$ / sharesshares
Class of Warrant or Right [Line Items]
Number of Warrants outstanding, Beginning Balance | shares
Number of Warrants, Granted | shares	900,000
Number of Warrants, Canceled or expired | shares
Number of Warrants, Exercised | shares
Number of Warrants, Outstanding Ending Balance | shares	900,000
Weighted-Average Price Per Share, Outstanding Beginning Balance | $ / shares
Weighted-Average Price Per Share, Granted | $ / shares	1
Weighted-Average Price Per Share, Canceled or expired | $ / shares
Weighted-Average Price Per Share, Exercised | $ / shares
Weighted-Average Price Per Share, Outstanding Ending Balance | $ / shares	$ 1

Warrants (Details 3)

Warrants (Details 3)	9 Months Ended
	May 31, 2017$ / shares
Minimum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.06%
Expected stock price volatility	117.00%
Expected dividend payout
Expected option in life-years	1 year
Maximum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.44%
Expected stock price volatility	36.00%
Expected dividend payout
Expected option in life-years	3 years

Warrants (Details Textual)

Warrants (Details Textual) - USD ($)	Apr. 11, 2017	May 22, 2017	May 31, 2017	May 31, 2016	Mar. 14, 2017
Warrants (Textual)
Exercise proceeds of warrants			$ 4,000
Convertible debenture			(540,000)
Mr. Tenzer [Member]
Warrants (Textual)
Warrant to purchase of common stock					20,000,000
Common stock per share price					$ 0.0001
Fair value of warrants			4,998,021
Mr. Yahr [Member]
Warrants (Textual)
Warrant to purchase of common stock		20,000,000
Common stock per share price		$ 0.0001
Fair value of warrants			10,998,105
Terms of warrants		3 years
Compensation expense recognized			90,400
Compensation expense recognized remaining period			$ 10,908,265
Compensation expense recognized over service period			3 years
Common stock shares unissued		20,000,000
Convertible Debt [Member]
Warrants (Textual)
Common stock per share price	$ 1
Fair value of warrants	$ 44,981		$ 202,490
Terms of warrants	3 years
Convertible debenture	$ 540,000
Original issue discount of convertible debt	$ 180,000
Interest rate	9.00%
Terms of convertible debt	2 years
Debt instrument warrants issued to lender	900,000
Warrants [Member] | Mr. Tenzer [Member]
Warrants (Textual)
Shares of stock issued upon warrant exercised and cancelled		20,000,000
Exercise proceeds of warrants		$ 2,000

Asset Purchase Agreement (Detai

Asset Purchase Agreement (Details) - USD ($)	May 31, 2017	Feb. 21, 2017	Aug. 31, 2016
Asset Purchase Agreement (Textual)
Total approximate amount include in asset purchase agreement		$ 20,000
Number of common stock	200,000	200,000
Common stock payable	$ 30,000
Common stock value		$ 30,000

Intellectual Property (Details)

Intellectual Property (Details) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2017	May 31, 2016	May 31, 2017	May 31, 2016
Intellectual Property (Textual)
Impairment of intellectual property			$ 1,248

Notes Payable (Details)

Notes Payable (Details) - 7% Unsecured promissory note [Member] - USD ($)	9 Months Ended	12 Months Ended
	May 31, 2017	Aug. 31, 2016
Shareholder [Member]
Debt Instrument [Line Items]
Notes payable - related party at beginning of period	$ 26,000
Payments on notes payable - related party
Borrowings on notes payable - related party	127,000	26,000
Convertible debenture - related party at end of period	153,000	26,000
Mr. Tenzer [Member]
Debt Instrument [Line Items]
Notes payable - related party at beginning of period	5,500
Payments on notes payable - related party	(5,500)
Borrowings on notes payable - related party	50	5,500
Convertible debenture - related party at end of period	$ 50	$ 5,500

Notes Payable (Details 1)

Notes Payable (Details 1)	May 31, 2017USD ($)
Notes Payable [Abstract]
Convertible debenture	$ 540,000
Unamortized discount	(371,139)
Convertible debenture, net of unamortized discount	$ 168,861

Notes Payable (Details Textual)

Notes Payable (Details Textual) - USD ($)

Apr. 11, 2017

Nov. 17, 2016

Nov. 14, 2016

Aug. 15, 2016

Jul. 05, 2016

Mar. 31, 2017

Feb. 17, 2017

Oct. 27, 2016

May 17, 2016

Apr. 27, 2016

May 31, 2017

May 31, 2016

Debt Instrument [Line Items]

Convertible debenture

$ (540,000)

Amortization of debt discount

11,351

Mr. Tenzer [Member]

Debt Instrument [Line Items]

Fair value of warrants

4,998,021

Convertible Debt [Member]

Debt Instrument [Line Items]

Unsecured debt, interest rate

9.00%

Convertible debenture

$ 540,000

Original issue discount of convertible debt

$ 180,000

Terms of convertible debt

2 years

Debt instrument warrants issued to lender

900,000

Debt instrument shares issued to lender

2,700,000

Fair value of warrants

$ 44,981

202,490

Amortization of debt discount

$ 11,351

Debt instrument, description

The conversion price of the outstanding balance is the lesser of $3.00 or 40% of the volume weighted average price of the 30 days at date of conversion; not to be less than $1.00. In connection with the note the lender is entitled to receive the greater of 5% every dollar raised through financing or every dollar of revenue generated through the earlier of maturity date and repayment of the principle.

7% Unsecured promissory note [Member] | Shareholder [Member]

Debt Instrument [Line Items]

Unsecured promissory note issued

$ 80,000

$ 16,000

$ 7,000

$ 30,000

$ 10,000

$ 10,000

Unsecured promissory note maturity, description

Matures six months from the date of issuance.

Matures six months from the date of issuance.

Matures six months from the date of issuance.

Matures six months from the date of issuance.

Matures six months from the date of issuance.

Matured six months from the date of issuance.

7% Unsecured promissory note [Member] | Mr. Tenzer [Member]

Debt Instrument [Line Items]

Unsecured promissory note issued

$ 3,000

$ 2,500

Repaid of principal amount

$ 5,500

Unsecured promissory note maturity, description

Matured six months from date of issuance.

Matured six months from the date of issuance.

Employment Agreement (Details)

Employment Agreement (Details) - $ / shares	1 Months Ended
	May 22, 2017	Mar. 14, 2017
Mr. Tenzer [Member]
Employment Agreement (Textual)
Warrant to purchase of common stock		20,000,000
Common stock per share price		$ 0.0001
President and Chief Executive Officer [Member]
Employment Agreement (Textual)
Warrant to purchase of common stock	20,000,000
Common stock per share price	$ 0.0001
Terms of warrants	3 years
Common stock shares unissued	20,000,000

Related Party Transactions (Det

Related Party Transactions (Details)	Nov. 14, 2016USD ($)	Aug. 15, 2016USD ($)	Jul. 05, 2016USD ($)	Mar. 31, 2017USD ($)	Feb. 17, 2017USD ($)	Oct. 27, 2016USD ($)	May 17, 2016USD ($)	Apr. 27, 2016USD ($)	May 31, 2017USD ($)ft²	Apr. 11, 2017USD ($)	Aug. 31, 2016USD ($)
Related Party Transactions (Textual)
Accounts payable - related party											$ 14,609
Principal amount										$ 540,000
Mr. Tenzer [Member]
Related Party Transactions (Textual)
Accounts payable - related party									$ 0
Related party outstanding payable											$ 14,609
7% Unsecured promissory note [Member] | Mr. Tenzer [Member]
Related Party Transactions (Textual)
Unsecured promissory note issued			$ 3,000					$ 2,500
Unsecured promissory note maturity, description			Matured six months from date of issuance.					Matured six months from the date of issuance.
7% Unsecured promissory note [Member] | CEO two [Member]
Related Party Transactions (Textual)
Unsecured promissory note issued								$ 5,500
Principal amount								$ 0
Unsecured promissory note maturity, description								Matured six months from the date of issuance.
Vice President [Member]
Related Party Transactions (Textual)
General office space lease (In square feet) | ft²									500
Shareholder [Member] | 7% Unsecured promissory note [Member]
Related Party Transactions (Textual)
Unsecured promissory note issued	$ 80,000	$ 16,000		$ 7,000	$ 30,000	$ 10,000	$ 10,000
Unsecured promissory note maturity, description	Matures six months from the date of issuance.	Matures six months from the date of issuance.		Matures six months from the date of issuance.	Matures six months from the date of issuance.	Matures six months from the date of issuance.	Matured six months from the date of issuance.

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jun. 10, 2017	Jun. 29, 2017	May 22, 2017	May 31, 2017	May 31, 2016
Subsequent Events (Textual)
Exercise proceeds of warrants				$ 4,000
Subsequent Events [Member]
Subsequent Events (Textual)
Shares of common stock issued for purchase of domain names		200,000
Aggregate common shares	40,000,000
Proceeds from warrants exercise	$ 4,000
CEO [Member] | Warrants [Member]
Subsequent Events (Textual)
Shares of stock issued upon warrant exercised and cancelled			20,000,000
Exercise proceeds of warrants			$ 2,000
CEO [Member] | Warrants [Member] | Subsequent Events [Member]
Subsequent Events (Textual)
Shares of stock issued upon warrant exercised and cancelled		20,000,000
Exercise proceeds of warrants		$ 2,000